利用组学进行子宫内膜周期定时:周期仍在推进
该文讨论利用组学技术对子宫内膜周期进行精确和个性化定时以优化胚胎移植的设想。作者指出,尽管组学技术被广泛倡导用于分期和定义植入所需的生化条件,但经过二十年研究,妊娠率并未随之改善,且对容受态分子特征的共识严重缺乏。作者建议在描述中避免暗示中分泌期分子分期方案本身即可识别对囊胚的容受状态。
要点
- 组学技术被广泛倡导用于子宫内膜周期分期和定义植入的生化条件,但二十年研究后妊娠率并未改善。
- 对容受态分子特征的共识严重缺乏,容受性可能是依赖多个低通路连通性蛋白的涌现特征。
- 作者建议避免暗示中分泌期分子分期方案本身即可识别对植入囊胚的容受状态。
核心结论
- 经过二十年组学研究,妊娠率并未随之改善,且对容受态分子特征缺乏共识。
- 容受性可能是依赖多个低通路连通性蛋白的涌现特征。
- 作者建议在语言上严格避免暗示中分泌期分子分期方案本身即可识别对植入囊胚的容受状态。
研究设计与样本
- 原文为综述/评论性文章,讨论利用组学技术进行子宫内膜周期定时的挑战。
主要发现
- 上个世纪在确切定时周期中定义了中分泌期形态学变化,但偏离标准日程时其对植入的意义仍不确定。
- 组学技术被广泛倡导用于子宫内膜周期分期和定义植入的生化条件,但二十年研究后妊娠率并未改善。
- 对容受态分子特征的共识严重缺乏。
临床怎么用
- 作者建议作者们选择语言时严格避免暗示中分泌期分子分期方案本身即可识别对植入囊胚的容受状态。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
For some years, the prospect of precise and personalized timing of the endometrial cycle for optimal embryo replacement has been held out as a potential solution to low implantation rates. It is envisaged that a receptive state can be defined and reached at a predictable time, and embryo replacement performed in synchrony. In the last century, morphological changes characteristic of the mid secretory phase were defined in precisely timed cycles in women of proven fertility, but when deviations from this standardized schedule occur, their significance for implantation has remained uncertain. 'Omics technologies have been widely advocated for staging the endometrial cycle and defining a set of biochemical requirements for implantation, but after two decades of research, improvements to pregnancy rates have not followed, and there is a striking lack of agreement regarding the molecular characterization of the receptive state. Some of the rationale underlying these problems is now emerging with the application of higher-level computational and biological methodology. Here, we consider the challenges of defining an endometrial phenotype that can support implantation and continuing pregnancy. Receptivity may be an emergent trait depending on contributions from multiple proteins that have low pathway connectivity. We recommend that authors choose language which rigorously avoids the implication that protocols for molecular staging of the mid secretory phase inherently identify a state of receptivity to the implanting blastocyst.
引用
- Aplin JD, Stevens A. Use of 'omics for endometrial timing: the cycle moves on. Hum Reprod. 2022. PMID: 35147196. doi:10.1093/humrep/deac022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。